ProShare Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

ProShare Advisors’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,017	Closed	-$63.3K	–	2044
2023 Q4	$63.3K	Buy	25,017 +5,382	+27%	+$12.5K	﹤0.01%	1833
2023 Q3	$46.9K	Sell	19,635 -23	-0.1%	-$51	﹤0.01%	1721
2023 Q2	$45.4K	Buy	19,658 +1,530	+8%	+$4.32K	﹤0.01%	1780
2023 Q1	$46.2K	Sell	18,128 -1,129	-6%	-$3.23K	﹤0.01%	1680
2022 Q4	$48.3K	Buy	19,257 +2,761	+17%	+$7.71K	﹤0.01%	1738
2022 Q3	$48K	Sell	16,496 -316	-2%	-$1.33K	﹤0.01%	1665
2022 Q2	$76K	Buy	+16,812	New	+$100K	﹤0.01%	1654

ProShare Advisors's SLGC Position: Q1 2024 in Review

ProShare Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 25,017 shares — an estimated $63.3K sold.

ProShare Advisors first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $76K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

ProShare Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
ProShare Advisors sold 25,017 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $63.3K.
ProShare Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
ProShare Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $76K in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.